The Contagion® Vaccines specialty page provides vaccine-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
In all trial participants to date, the vaccine candidate led to seroconversion with binding antibody levels either at or above levels seen in convalescent sera.
